Samsung Epis Holdings Co Ltd
KRX:0126Z0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
KR |
|
H
|
Hareket Proje Tasimaciligi ve Yuk Muhendisligi AS
IST:HRKET.E
|
TR |
Samsung Epis Holdings Co Ltd
Samsung Epis Holdings Co Ltd is a KR-based company operating in Biotechnology industry. The company is headquartered in Incheon, Incheon. The company went IPO on 2025-11-24. Samsung Epis Holdings Co Ltd is a Korea-based company primarily engaged in the manufacturing of biosimilar products. The firm primarily focuses on the research, development, production, and sales of biosimilars, and also develops a new drug pipeline, including antibody-drug conjugates and gene therapies. The firm also engages in platform development, including peptide-related element technologies.
Samsung Epis Holdings Co Ltd is a KR-based company operating in Biotechnology industry. The company is headquartered in Incheon, Incheon. The company went IPO on 2025-11-24. Samsung Epis Holdings Co Ltd is a Korea-based company primarily engaged in the manufacturing of biosimilar products. The firm primarily focuses on the research, development, production, and sales of biosimilars, and also develops a new drug pipeline, including antibody-drug conjugates and gene therapies. The firm also engages in platform development, including peptide-related element technologies.
